GWS
RGNX icon

Glassman Wealth Services’s Regenxbio RGNX Stock Holding History

Glassman Wealth Services’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-180
Closed -$3.6K – 2050
2023
Q2 		$3.6K Buy
+180
New +$3.47K ﹤0.01% 1081
2019
Q3 		– Sell
-19
Closed -$1K – 1321
2019
Q2 		$1K Hold
19
– – ﹤0.01% 914
2019
Q1 		$1K Buy
+19
New +$941 ﹤0.01% 871

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Glassman Wealth Services's RGNX Position: Q3 2023 in Review

Glassman Wealth Services sold out of Regenxbio (RGNX) in Q3 2023, closing a stake of 180 shares — an estimated $3.6K sold.

Glassman Wealth Services first reported a position in RGNX in Q1 2019 and held it in 3 quarters. The position peaked at $3.6K in Q2 2023. 159 funds tracked by Wall St. Rank hold RGNX as of Q3 2023.

  • Glassman Wealth Services reported no remaining Regenxbio position as of Q3 2023 after selling out during the quarter.
  • Glassman Wealth Services sold 180 Regenxbio shares in Q3 2023, an estimated $3.6K.
  • Glassman Wealth Services first reported a position in Regenxbio in Q1 2019 and held it in 3 quarters.
  • Glassman Wealth Services's Regenxbio position peaked at $3.6K in Q2 2023.
  • 159 funds tracked by Wall St. Rank held Regenxbio as of Q3 2023.

Based on Glassman Wealth Services's 13F filing for Q3 2023, filed 14 Nov 2023.